Combination of Eflornithine and Lomustine Demonstrates Clinically Meaningful Improvements in Overall Survival (OS) and Progression Free Survival (PFS) in Patients with Recurrent Astrocytoma, IDH Mutant Grade 3
November 22, 2024 11:00 ET | Source: Orbus Therapeutics, Inc. – OS…
Robust operational Growth, Strong legacy book run-down traction and Net worth grows to ~INR 20,000 Crs.
Subsidiary Sammaan Finserve reoriented as Affordable Housing FinancierMUMBAI, India, Nov. 18, 2024…
GE HealthCare Technologies Inc. Prices Secondary Offering of 13,281,302 Shares
CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”)…
Corebridge Financial Announces Pricing of Secondary Offering of Common Stock by AIG
HOUSTON--(BUSINESS WIRE)--Corebridge Financial, Inc. (NYSE: CRBG) today announced that the previously announced…
Cytek Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
FREMONT, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq:…
Straight Arrow News Adds Ken Shapiro as Chief Revenue Officer
Shapiro Previously Served as Chief Revenue Officer at Morning Brew and Fandom…